Tag: Gene Therapy Platform
PharmaSignal — Gene Therapy Platform
Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine
BioPharma Dive
The startup is developing modified DNA therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy.
Eli Lilly doubles down on in vivo with $7bn Kelonia buyout
Pharmaceutical Technology
Lilly now has a lentiviral and LNP-based platform for in vivo delivery under its belt, which could broaden the company’s chance of success.
Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout
BioPharma Dive
Worth up to $7 billion, Lilly s second recent acquisition of a company in the space is centered around a cell therapy that s currently in early-stage testing for multiple myeloma.
Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal
BioSpace
After entering the CAR T space in February, Eli Lilly is “jumping into in vivo CAR-T with both feet” with the acquisition of Kelonia Therapeutics and its gene delivery technology.
The innovators working to make in vivo cell therapy a reality
Pharmaceutical Technology
As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.
219: An Interview With Dr. Natalie Truba on the Psychological Aspects of Gene Therapy
Rare Disease Audio
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews pediatric psychologist Natalie Truba, PhD, on the psychological aspects of gene therapy in neuromuscular disease.